Cargando…
Bladder urothelial carcinoma producing insulin‐like growth factor II: A case report
INTRODUCTION: Non‐islet cell tumor hypoglycemia is a rare paraneoplastic syndrome associated with tumors. Although it mainly occurs in solid tumors of mesenchymal and epithelial origin, but rarely also in hematopoietic and neuroendocrine origin. CASE PRESENTATION: We describe a 65‐year‐old man with...
Autores principales: | Funada, Satoshi, Kita, Yuki, Okada, Yoshiyuki, Kobayashi, Takashi, Teramoto, Yuki, Shibuya, Shinsuke, Saito, Ryoichi, Murakami, Kaoru, Matsumoto, Keiyu, Yang, Feng, Dimitrov, Dimiter S, Inoue, Takahiro, Ogawa, Osamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292130/ https://www.ncbi.nlm.nih.gov/pubmed/32743354 http://dx.doi.org/10.1002/iju5.12018 |
Ejemplares similares
-
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies
por: Kita, Yuki, et al.
Publicado: (2019) -
Antitumor effect of WEE1 blockade as monotherapy or in combination with cisplatin in urothelial cancer
por: Murakami, Kaoru, et al.
Publicado: (2021) -
Expression and Role of GPR87 in Urothelial Carcinoma of the Bladder
por: Okazoe, Homare, et al.
Publicado: (2013) -
Consecutive Prostate Cancer Specimens Revealed Increased Aldo–Keto Reductase Family 1 Member C3 Expression with Progression to Castration-Resistant Prostate Cancer
por: Miyazaki, Yu, et al.
Publicado: (2019) -
Toxic epidermal necrolysis after the administration of enfortumab vedotin for urinary bladder urothelial carcinoma
por: Mimura, Yuji, et al.
Publicado: (2022)